Tyche Industries Ltd (TYCHE) — shareholding pattern, promoter holding, financials and share price
About Tyche Industries Ltd (TYCHE)
Tyche Industries Ltd operates in the Pharmaceuticals industry, within the Healthcare sector. It trades on the NSE as TYCHE and on the BSE under scrip code 532384. Its ISIN is INE443B01012.
Incorporated in 1998, Tyche Industries Ltd does manufacturing of active pharmaceutical ingredients [1]
Tyche Industries Limited is a major manufacturer of Glucosamine Hydrochloride and its salts, primarily exporting to the USA and Europe.
The company operates in the bulk drugs intermediate manufacturing sector and has expanded its infrastructure for future growth.
Listed peers in Pharmaceuticals: Bal Pharma Ltd, Lactose (India) Ltd, Godavari Drugs Ltd, Pharmaids Pharmaceuticals Ltd, Krebs Biochemicals & Industries Ltd, Sotac Pharmaceuticals Ltd.
Valuation & Returns
10 Jul 2026At ₹122.1 a share on 10 Jul 2026, Tyche Industries Ltd (TYCHE) was valued at a price-to-earnings ratio of 18.09x and a price-to-book of 0.92x on a book value of ₹133.37 per share as of Mar 2025. Solomo computes return on equity of 5.06% and return on capital employed of 6.93% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 18.09x
- P/B
- 0.92x
- EPS (TTM)
- ₹6.75
- Book value / share
- ₹133.37
- ROE
- 5.06%
- ROCE
- 6.93%
- ROA
- 4.69%
- Debt / equity
- 0x
- Dividend yield
- 2.46%
- EBITDA margin
- 10.85%
- 52-week range
- ₹59.69 – ₹112.97
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Tyche Industries Ltd (TYCHE) reported revenue of ₹53.63 crore, net profit of ₹6.94 crore and earnings per share of ₹6.77. That compares with revenue of ₹65.47 crore and net profit of ₹12.41 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹16.2 crore and net profit ₹1.15 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 62.27 | 75.39 | 69.51 | 65.47 | 53.63 |
| Net profit (₹ cr) | 9.33 | 14.17 | 12.24 | 12.41 | 6.94 |
| EPS (₹) | 9.1 | 13.82 | 11.94 | 12.11 | 6.77 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 1.77% | -2.34% | 1.69% | -5.81% |
| Profit growth | 19.66% | -6.71% | 9.96% | 1.39% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 61.97% of Tyche Industries Ltd (TYCHE) (unchanged from the previous quarter). Market capitalisation was ₹125 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: PLUTUS TECHLABS PRIVATE LIMITED 6.4%, Investor Education and Protection Fund 1.48%, LINCOLN P COELHO 1.46%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 61.97% | - | - | - | 38.03% |
| Mar 2026 | 61.97% | - | - | - | 38.03% |
| Dec 2025 | 61.97% | - | - | - | 38.03% |
| Sep 2025 | 62.05% | - | - | - | 37.95% |
| Jun 2025 | 61.97% | - | - | - | 38.03% |
| Mar 2025 | 61.97% | - | - | - | 38.03% |
| Dec 2024 | 61.97% | - | - | - | 38.03% |
| Sep 2024 | 61.97% | - | - | - | 38.03% |